Suppr超能文献

mPPARγ2:脂肪细胞增强子的组织特异性调节因子。

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.

作者信息

Tontonoz P, Hu E, Graves R A, Budavari A I, Spiegelman B M

机构信息

Dana-Farber Cancer Institute, Boston, Massachusetts.

出版信息

Genes Dev. 1994 May 15;8(10):1224-34. doi: 10.1101/gad.8.10.1224.

Abstract

Previously, we have isolated and characterized an enhancer from the 5'-flanking region of the adipocyte P2 (aP2) gene that directs high-level adipocyte-specific gene expression in both cultured cells and transgenic mice. The key regulator of this enhancer is a cell type-restricted nuclear factor termed ARF6. Target sequences for ARF6 in the aP2 enhancer exhibit homology to a direct repeat of hormone response elements (HREs) spaced by one nucleotide; this motif (DR-1) has been demonstrated previously to be the preferred binding site for heterodimers of the retinoid X receptor (RXR) and the peroxisome proliferator-activated receptor (PPAR). We have cloned a novel member of the peroxisome proliferator-activated receptor family designated mPPAR gamma 2, and we demonstrate that a heterodimeric complex of mPPAR gamma 2 and RXR alpha constitute a functional ARF6 complex. Expression of mPPAR gamma 2 is induced very early during the differentiation of several cultured adipocyte cell lines and is strikingly adipose-specific in vivo. mPPAR gamma 2 and RXR alpha form heterodimers on ARF6-binding sites in vitro, and antiserum to RXR alpha specifically inhibits ARF6 activity in adipocyte nuclear extracts. Moreover, forced expression of mPPAR gamma 2 and RXR alpha activates the adipocyte-specific aP2 enhancer in cultured fibroblasts, and this activation is potentiated by peroxisome proliferators, fatty acids, and 9-cis retinoic acid. These results identify mPPAR gamma 2 as the first adipocyte-specific transcription factor and suggest mechanisms whereby fatty acids, peroxisome proliferators, 9-cis retinoic acid, and other lipids may regulate adipocyte gene expression and differentiation.

摘要

此前,我们已从脂肪细胞P2(aP2)基因的5'侧翼区域分离并鉴定出一种增强子,该增强子在培养细胞和转基因小鼠中均能指导高水平的脂肪细胞特异性基因表达。这种增强子的关键调节因子是一种细胞类型受限的核因子,称为ARF6。aP2增强子中ARF6的靶序列与间隔一个核苷酸的激素反应元件(HREs)直接重复序列具有同源性;此前已证明该基序(DR-1)是视黄酸X受体(RXR)和过氧化物酶体增殖物激活受体(PPAR)异二聚体的首选结合位点。我们克隆了过氧化物酶体增殖物激活受体家族的一个新成员,命名为mPPARγ2,并证明mPPARγ2和RXRα的异二聚体复合物构成功能性ARF6复合物。mPPARγ2的表达在几种培养的脂肪细胞系分化过程中很早就被诱导,并且在体内具有显著的脂肪特异性。mPPARγ2和RXRα在体外ARF6结合位点上形成异二聚体,抗RXRα血清可特异性抑制脂肪细胞核提取物中的ARF6活性。此外,mPPARγ2和RXRα的强制表达可激活培养的成纤维细胞中脂肪细胞特异性的aP2增强子,而过氧化物酶体增殖物、脂肪酸和9-顺式视黄酸可增强这种激活作用。这些结果确定mPPARγ2为首个脂肪细胞特异性转录因子,并提示脂肪酸、过氧化物酶体增殖物、9-顺式视黄酸和其他脂质可能调节脂肪细胞基因表达和分化的机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验